Creative Planning’s PRA Health Sciences, Inc. PRAH Stock Holding History

Creative Planning’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,104	Closed	-$605K	–	2140
2019 Q2	$605K	Buy	6,104 +1,465	+32%	+$140K	﹤0.01%	973
2019 Q1	$512K	Buy	+4,639	New	+$485K	﹤0.01%	1018
2018 Q4	–	Sell	-3,308	Closed	-$365K	–	2163
2018 Q3	$365K	Buy	3,308 +945	+40%	+$98.4K	﹤0.01%	1274
2018 Q2	$221K	Buy	+2,363	New	+$203K	﹤0.01%	1577
2017 Q3	–	Sell	-316	Closed	-$24K	–	4112
2017 Q2	$24K	Buy	316 +312	+7,800%	+$21.6K	﹤0.01%	3068
2017 Q1	$0	Hold	4	–	–	﹤0.01%	5007
2016 Q4	$0	Buy	+4	New	+$220	﹤0.01%	4937
2016 Q3	–	Sell	-17	Closed	-$1K	–	4798
2016 Q2	$1K	Buy	17 +10	+143%	+$461	﹤0.01%	4257
2016 Q1	$0	Sell	7 -293	-98%	-$12.4K	﹤0.01%	4621
2015 Q4	$14K	Sell	300 -4,399	-94%	-$185K	﹤0.01%	3088
2015 Q3	$182K	Buy	+4,699	New	+$188K	﹤0.01%	1249

Other funds holding PRAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Creative Planning's PRAH Position: Q3 2019 in Review

Creative Planning sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2019, closing a stake of 6,104 shares — an estimated $605K sold.

Creative Planning first reported a position in PRAH in Q3 2015 and held it in 11 quarters. The position peaked at $605K in Q2 2019. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

Creative Planning reported no remaining PRA Health Sciences, Inc. position as of Q3 2019 after selling out during the quarter.
Creative Planning sold 6,104 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $605K.
Creative Planning first reported a position in PRA Health Sciences, Inc. in Q3 2015 and held it in 11 quarters.
Creative Planning's PRA Health Sciences, Inc. position peaked at $605K in Q2 2019.
329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.